Age-associated motor and visuo-spatial learning phenotype in Dyrk1A heterozygous mutant mice

Neurobiology of Disease

Volumn 36, Issue 2, 2009, Pages 312-319

  Arqué, Glòria ^a   de Lagrán, María Martínez ^a   Arbonés, Maria L ^a   Dierssen, Mara ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

Aging; DYRK1A; Motor dysfunction; Radial arm water maze; Visuo spatial learning and memory

Indexed keywords

DUAL SPECIFICITY TYROSINE REGULATED KINASE 1A; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENTATE GYRUS; GENE DOSAGE; HETEROZYGOSITY; HIPPOCAMPUS; LEARNING; MEMORY DISORDER; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; SPATIAL MEMORY; VISUAL MEMORY;

AGING; ANIMALS; BRAIN; COGNITION DISORDERS; FEMALE; HETEROZYGOTE DETECTION; LEARNING; MALE; MICE; MICE, INBRED C57BL; MICE, NEUROLOGIC MUTANTS; MOTOR ACTIVITY; MUTATION; ORGAN SIZE; PHENOTYPE; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; PSYCHOMOTOR PERFORMANCE; SPATIAL BEHAVIOR;

EID: 70349758084     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2009.07.027     Document Type: Article

References (52)

1. Ahn K.J., et al. DYRK1A BAC transgenic mice show altered synaptic plasticity with learning and memory defects. Neurobiol. Dis. 22 (2006) 463-472
2. Altafaj X., et al. Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome. Hum. Mol. Genet. 10 (2001) 1915-1923
3. Arendash G.W., et al. Behavioral assessment of Alzheimer's transgenic mice following long-term Abeta vaccination: task specificity and correlations between Abeta deposition and spatial memory. DNA Cell Biol. 20 (2001) 737-744
4. Arque G., et al. Impaired spatial learning strategies and novel object recognition in mice haploinsufficient for the dual specificity tyrosine-regulated kinase-1A (Dyrk1A). PLoS ONE 3 (2008) e2575
5. Benavides-Piccione R., et al. Alterations in the phenotype of neocortical pyramidal cells in the Dyrk1A+/- mouse. Neurobiol. Dis. 20 (2005) 115-122
6. Casas C., et al. Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model. Am. J. Pathol. 165 (2004) 1289-1300
7. Costa A.C., et al. Motor dysfunction in a mouse model for Down syndrome. Physiol. Behav. 68 (1999) 211-220
8. Dierssen M., and de Lagran M.M. DYRK1A (dual-specificity tyrosine-phosphorylated and -regulated kinase 1A): a gene with dosage effect during development and neurogenesis. Scientific World Journal 6 (2006) 1911-1922
9. Dierssen M., and Ramakers G.J.A. Dendritic pathology in mental retardation: from molecular genetics to neurobiology. Genes, Brain Behav. 5 (2006) 48-60
10. Dierssen M., et al. Transgenic mice overexpressing the full-length neurotrophin receptor TrkC exhibit increased catecholaminergic neuron density in specific brain areas and increased anxiety-like behavior and panic reaction. Neurobiol. Dis. 24 (2006) 403-418
11. Dierssen M., Herault Y., and Estivill X. Aneuploidy: from a physiological mechanism of variance to Down syndrome. Physiol. Rev. 89 (2009) 887-920
12. Divac I. Magnocellular nuclei of the basal forebrain project to neocortex, brain stem, and olfactory bulb. Review of some functional correlates. Brain Res. 93 (1975) 385-398
13. Dowjat W.K., et al. Trisomy-driven overexpression of DYRK1A kinase in the brain of subjects with Down syndrome. Neurosci. Lett. 413 (2007) 77-81
14. Ewers M., et al. Associative and motor learning in 12-month-old transgenic APP+PS1 mice. Neurobiol. Aging 27 (2006) 1118-1128
15. Ferrer I., et al. Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models. Neurobiol. Dis. 20 (2005) 392-400
16. Fotaki V., et al. Dyrk1A haploinsufficiency affects viability and causes developmental delay and abnormal brain morphology in mice. Mol. Cell Biol. 22 (2002) 6636-6647
17. Fotaki V., et al. Haploinsufficiency of Dyrk1A in mice leads to specific alterations in the development and regulation of motor activity. Behav. Neurosci. 118 (2004) 815-821
18. Guimera J., et al. A human homologue of Drosophila minibrain (MNB) is expressed in the neuronal regions affected in Down syndrome and maps to the critical region. Hum. Mol. Genet. 5 (1996) 1305-1310
19. Guimera J., et al. Human minibrain homologue (MNBH/DYRK1): characterization, alternative splicing, differential tissue expression, and overexpression in Down syndrome. Genomics 57 (1999) 407-418
20. Hammerle B., et al. The spatio-temporal and subcellular expression of the candidate Down syndrome gene Mnb/Dyrk1A in the developing mouse brain suggests distinct sequential roles in neuronal development. Eur. J. Neurosci. 27 (2008) 1061-1074
21. Hyde L.A., et al. Water version of the radial-arm maze: learning in three inbred strains of mice. Brain Res. 785 (1998) 236-244
22. Jarrard L.E., et al. On the role of hippocampal connections in the performance of place and cue tasks: comparisons with damage to hippocampus. Behav. Neurosci. 98 (1984) 946-954
23. Kimura R., et al. The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between beta-amyloid production and tau phosphorylation in Alzheimer disease. Hum. Mol. Genet. 16 (2007) 15-23
24. Lewis J., et al. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat. Genet. 25 (2000) 402-405
25. Liu F., et al. Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndrome. FASEB J. 22 (2008) 3224-3233
26. Lovasic L., et al. Working memory impairment in a transgenic amyloid precursor protein TgCRND8 mouse model of Alzheimer's disease. Genes Brain Behav. 4 (2005) 197-208
27. Lumbreras M., et al. Brain G protein-dependent signaling pathways in Down syndrome and Alzheimer's disease. Amino Acids 31 (2006) 449-456
28. Marti E., et al. Dyrk1A expression pattern supports specific roles of this kinase in the adult central nervous system. Brain Res. 964 (2003) 250-263
29. Martinez de Lagran M., et al. Motor phenotypic alterations in TgDyrk1a transgenic mice implicate DYRK1A in Down syndrome motor dysfunction. Neurobiol. Dis. 15 (2004) 132-142
30. Martinez de Lagran M., et al. Dopaminergic deficiency in mice with reduced levels of the dual-specificity tyrosine-phosphorylated and regulated kinase 1A, Dyrk1A(+/-). Genes Brain Behav. 6 (2007) 569-578
31. Moller R.S., et al. Truncation of the Down syndrome candidate gene DYRK1A in two unrelated patients with microcephaly. Am. J. Hum. Genet. 82 (2008) 1165-1170
32. Murphy M.P., and Golde T.E. Inclusion-body myositis and Alzheimer disease: two sides of the same coin, or different currencies altogether?. Neurology 66 (2006) S65-S68
33. O'Keeffe S.T., et al. Gait disturbance in Alzheimer's disease: a clinical study. Age Ageing 25 (1996) 313-316
34. Paxinos G.F., and Franklin K.B.J. The Mouse Brain in Stereotaxic Coordinates (2001), Academic Press, San Diego
35. Pettersson A.F., et al. Activity level and balance in subjects with mild Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 13 (2002) 213-216
36. Rahmani Z., et al. Critical role of the D21S55 region on chromosome 21 in the pathogenesis of Down syndrome. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 5958-5962
37. Rahmani Z., et al. Expression of the mnb (dyrk) protein in adult and embryonic mouse tissues. Biochem. Biophys. Res. Commun. 253 (1998) 514-518
38. Rogers D.C., et al. Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm. Genome. 8 (1997) 711-713
39. Ryoo S.R., et al. DYRK1A-mediated hyperphosphorylation of Tau. A functional link between Down syndrome and Alzheimer disease. J. Biol. Chem. 282 (2007) 34850-34857
40. Ryoo S.R., et al. Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease. J. Neurochem. 104 (2008) 1333-1344
41. Sago H., et al. Genetic dissection of region associated with behavioral abnormalities in mouse models for Down syndrome. Pediatr. Res. 48 (2000) 606-613
42. Scarmeas N., et al. Motor signs during the course of Alzheimer disease. Neurology 63 (2004) 975-982
43. Scarmeas N., et al. Motor signs predict poor outcomes in Alzheimer disease. Neurology 64 (2005) 1696-1703
44. Shin J.H., et al. Dysregulation of growth factor receptor-bound protein 2 and fascin in hippocampus of mice polytransgenic for chromosome 21 structures. Hippocampus 17 (2007) 1180-1192
45. Song W.J., et al. Isolation of human and murine homologues of the Drosophila minibrain gene: human homologue maps to 21q22.2 in the Down syndrome "critical region". Genomics 38 (1996) 331-339
46. Spittaels K., et al. Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. Am. J. Pathol. 155 (1999) 2153-2165
47. Tejedor F., et al. minibrain: a new protein kinase family involved in postembryonic neurogenesis in Drosophila. Neuron 14 (1995) 287-301
48. Terwel D., et al. Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R/2N transgenic mice. J. Biol. Chem. 280 (2005) 3963-3973
49. Trollor J.N., and Valenzuela M.J. Brain ageing in the new millennium. Aust. N Z J Psychiatry 35 (2001) 788-805
50. Wegiel J., et al. Cell type- and brain structure-specific patterns of distribution of minibrain kinase in human brain. Brain Res. 1010 (2004) 69-80
51. Wegiel J., et al. The role of overexpressed DYRK1A protein in the early onset of neurofibrillary degeneration in Down syndrome. Acta Neuropathol. 116 (2008) 391-407
52. Woods Y.L., et al. The kinase DYRK1A phosphorylates the transcription factor FKHR at Ser329 in vitro, a novel in vivo phosphorylation site. Biochem. J. 355 (2001) 597-607